Rizzo, A.; Imperiale, A.; Annunziata, S.; Delgado Bolton, R.C.; Albano, D.; Fiz, F.; Piccardo, A.; Cuzzocrea, M.; Paone, G.; Treglia, G.
Efficacy and Safety of Radioligand Therapy with Actinium-225 DOTATATE in Patients with Advanced, Metastatic or Inoperable Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis. Medicina 2025, 61, 1341.
https://doi.org/10.3390/medicina61081341
AMA Style
Rizzo A, Imperiale A, Annunziata S, Delgado Bolton RC, Albano D, Fiz F, Piccardo A, Cuzzocrea M, Paone G, Treglia G.
Efficacy and Safety of Radioligand Therapy with Actinium-225 DOTATATE in Patients with Advanced, Metastatic or Inoperable Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis. Medicina. 2025; 61(8):1341.
https://doi.org/10.3390/medicina61081341
Chicago/Turabian Style
Rizzo, Alessio, Alessio Imperiale, Salvatore Annunziata, Roberto C. Delgado Bolton, Domenico Albano, Francesco Fiz, Arnoldo Piccardo, Marco Cuzzocrea, Gaetano Paone, and Giorgio Treglia.
2025. "Efficacy and Safety of Radioligand Therapy with Actinium-225 DOTATATE in Patients with Advanced, Metastatic or Inoperable Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis" Medicina 61, no. 8: 1341.
https://doi.org/10.3390/medicina61081341
APA Style
Rizzo, A., Imperiale, A., Annunziata, S., Delgado Bolton, R. C., Albano, D., Fiz, F., Piccardo, A., Cuzzocrea, M., Paone, G., & Treglia, G.
(2025). Efficacy and Safety of Radioligand Therapy with Actinium-225 DOTATATE in Patients with Advanced, Metastatic or Inoperable Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis. Medicina, 61(8), 1341.
https://doi.org/10.3390/medicina61081341
